课题基金 / 基金详情

In vitro and In vivo evaluation of Radioiodinated (-) -m-iodovesamicol : Potential radioligand for diagnosing Alzheimer's disease.

In vitro and In vivo evaluation of Radioiodinated (-) -m-iodovesamicol : Potential radioligand for diagnosing Alzheimer's disease.
放射性碘标记 (-)-m-iodovesamicol 的体外和体内评估:用于诊断阿尔茨海默病的潜在放射性配体。
批准号:
08671010
负责人:
SHIBA Kazuhiro
金额:
$1.22万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1997

项目摘要

项目成果

SHIBA Kazuhiro的其他基金

相似基金

相关文献

中文摘要
翻译
本研究的目的是开发一种新的突触前胆碱能神经元作图剂。我们合成了在4-苯基哌啶部分位放射碘化的左旋异构体(-)-m-碘维酰胺((-)mIV),并评价了[I-125] (-) -mIV对大鼠脑内维酰胺受体的体外和体内结合亲和力和特异性,进一步评价了[I-125] (-) -mIV在阿尔茨海默病模型大鼠体内的特性。在体外和体内,[I-125] (-) - miv对维萨霉素受体(乙酰胆碱转运体)的结合亲和力非常高,与(-)-维萨霉素的结合亲和力相当;对多巴胺、血清素、去甲肾上腺素、乙酰胆碱和sigma受体的结合亲和力较低。这些相似的结果来源于饱和结合研究;[I-125] (-) - miv的Kd (18.2nM)和Bmax (660 fmol/mg蛋白)与(-)-vesamicol (Kd=20-30nM,Bmax=334-516fmol/mg蛋白)相当。此外,使用[I-125] (-) - miv和[Tc-99m] HMPAO在阿尔茨海默病模型大鼠脑中的双示踪自显影显示,在单侧胆碱能去神经控制模型中,基底前脑病变同侧投射皮质中[I-125] (-) - miv的积累显著减少11%,该模型被认为是阿尔茨海默病的实验模型。各区域[I-125] (-) - miv累积减少率为11%,[Tc-99m] HMPAO累积减少率为4%,差异有统计学意义(P<0.01)。这些结果表明,放射性碘化(-)- miv可能作为一种有用的放射配体,用于定位突触前胆碱能神经元。
英文摘要
The purpose of this investigation is to develop a new presynaptic cholinergic neuron mapping agent. We synthesized levorotatory isomer (-) -m-iodovesamicol ((-) mIV) radioiodinated at the meta position of the 4-phenylpiperidine moiety and evaluated the in vitro and in vivo binding affinity and specificity of [I-125] (-) -mIV for the vesamicol receptor in rat brain, furthermore, evaluated the in vivo characteristics of [I-125] (-) -mIV in the model rat of Alzheimer's disease. In vitro and In vivo binding affinity of [I-125] (-) -mIV for the vesamicol receptor (acetylcholine transporter) was very high and comparable to that of (-) -vesamicol ; the binding affinity for dopamine, serotonin, noradrenaline, acetylcholine and sigma receptors was low. These similar results were derived from saturation binding study ; Kd (18.2nM) and Bmax (660 fmol/mg of protein) of [I-125] (-) -mIV were comparable to those of (-) -vesamicol (Kd=20-30nM,Bmax=334-516fmol/mg of protein). Furthermore, double-tracer autoradiograms using [I-125] (-) -mIV and [Tc-99m] HMPAO in model rat brain of Alzheimer's disease showed a significant 11% decrease of the accumulation of [I-125] (-) -mIV in the projection cortices ipsilateral to the basalforebrain lesion in a unilateral cholinergic denervation model, which is regarded as an experimental model of Alzheimer's disease. The difference between the decrease of the accumulation of [I-125] (-) -mIV (11%) and that of [Tc-99m] HMPAO (4%) in the regions was statistically significant (P<0.01). These results suggest that radioiodinated (-) -mIV may serve as a useful radioligand for mapping presynaptic cholinergic neurons.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
柴 和弘: "Radioiodinated(-)-2-[4-(3-iodophenyl)piperidino]cyclohexanol:A potential radioligand for mapping presynaptic cholinergic neurons" Nuclear Medicine Communications. 17. 485-492 (1996)
Kazuhiro Shiba:“放射碘化(-)-2-[4-(3-碘苯基)哌啶基]环己醇:用于绘制突触前胆碱能神经元的潜在放射性配体”《核医学通讯》17. 485-492(1996)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Development of the Colin transporter imaging agent for early diagnosis of Alzheimer's disease
  • 批准号:
    23591813
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.24万
  • 财政年份:
    2011
  • 负责人:
    SHIBA Kazuhiro
  • 依托单位:
Development of pre-synaptic cholinergic nervous system imaging agent for Alzheimer's disease early diagnosis
  • 批准号:
    19390316
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $7.9万
  • 财政年份:
    2007
  • 负责人:
    SHIBA Kazuhiro
  • 依托单位:
A study about "the early diagnosis of the Alzheimer's disease" by the new transporter mapping agent
  • 批准号:
    17591257
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.24万
  • 财政年份:
    2005
  • 负责人:
    SHIBA Kazuhiro
  • 依托单位:
The development of radiolabeled molecular imaging agents for diagnosing Alzheimer's disease.
  • 批准号:
    14570845
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.18万
  • 财政年份:
    2002
  • 负责人:
    SHIBA Kazuhiro
  • 依托单位:
海外基金